AAUM (Average Assets Under Management) of ₹48.15 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.9% | 79.8% | ▲ +1.0% |
| Healthcare Services | 20.4% | 19.3% | ▼ -1.2% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.8% | 80.7% | ▲ +0.9% |
| Healthcare Services | 19.3% | 18.5% | ▼ -0.8% |
| Healthcare Equipment & Supplies | 1.0% | 0.8% | ▼ -0.2% |
Comparing Sep 2026 → Oct 2026
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Laurus Labs Limited ₹7.90 Cr |
Pharmaceuticals & Biotechnology | 11.83% | 14.09% | +2.26% |
| 2 | Acutaas Chemicals Ltd ₹1.75 Cr |
Pharmaceuticals & Biotechnology | 2.61% | 3.12% | +0.51% |
| 3 | Piramal Pharma Limited ₹1.25 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 2.23% | +0.26% |
| 4 | Gland Pharma Limited ₹2.08 Cr |
Pharmaceuticals & Biotechnology | 3.54% | 3.71% | +0.17% |
| 5 | Syngene International Limited ₹64.49 L |
Healthcare Services | 1.06% | 1.15% | +0.09% |
| 6 | Natco Pharma Limited ₹64.93 L |
Pharmaceuticals & Biotechnology | 1.14% | 1.16% | +0.02% |
| 7 | Sai Life Sciences Limited ₹1.82 Cr |
Pharmaceuticals & Biotechnology | 3.23% | 3.24% | +0.01% |
| 8 | Onesource Specialty Pharma Limited ₹1.04 Cr |
Pharmaceuticals & Biotechnology | 1.84% | 1.85% | +0.01% |
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Wockhardt Limited ₹1.32 Cr |
Pharmaceuticals & Biotechnology | 2.68% | 2.36% | -0.32% |
| 2 | Biocon Limited ₹2.07 Cr |
Pharmaceuticals & Biotechnology | 3.96% | 3.69% | -0.27% |
| 3 | Neuland Laboratories Limited ₹1.43 Cr |
Pharmaceuticals & Biotechnology | 2.82% | 2.55% | -0.27% |
| 4 | Krishna Institute Of Medical Sciences Limited ₹1.58 Cr |
Healthcare Services | 3.06% | 2.82% | -0.24% |
| 5 | Lupin Limited ₹4.12 Cr |
Pharmaceuticals & Biotechnology | 7.57% | 7.35% | -0.22% |
| 6 | GlaxoSmithKline Pharmaceuticals Limited ₹87.10 L |
Pharmaceuticals & Biotechnology | 1.76% | 1.55% | -0.21% |
| 7 | Glenmark Pharmaceuticals Limited ₹2.92 Cr |
Pharmaceuticals & Biotechnology | 5.39% | 5.20% | -0.19% |
| 8 | Global Health Limited ₹94.94 L |
Healthcare Services | 1.86% | 1.69% | -0.17% |
| 9 | Abbott India Limited ₹1.13 Cr |
Pharmaceuticals & Biotechnology | 2.17% | 2.01% | -0.16% |
| 10 | Poly Medicure Limited ₹46.67 L |
Healthcare Equipment & Supplies | 0.98% | 0.83% | -0.15% |
30 stocks — Oct 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹7.90 Cr |
Pharmaceuticals & Biotechnology |
14.09%
|
|
| 2 |
₹4.12 Cr |
Pharmaceuticals & Biotechnology |
7.35%
|
|
| 3 |
₹3.92 Cr |
Pharmaceuticals & Biotechnology |
6.99%
|
|
| 4 |
₹3.38 Cr |
Healthcare Services |
6.02%
|
|
| 5 |
₹2.92 Cr |
Pharmaceuticals & Biotechnology |
5.20%
|
|
| 6 |
₹2.60 Cr |
Pharmaceuticals & Biotechnology |
4.64%
|
|
| 7 |
₹2.38 Cr |
Pharmaceuticals & Biotechnology |
4.25%
|
|
| 8 |
₹2.26 Cr |
Pharmaceuticals & Biotechnology |
4.03%
|
|
| 9 |
₹2.08 Cr |
Pharmaceuticals & Biotechnology |
3.71%
|
|
| 10 |
₹2.07 Cr |
Pharmaceuticals & Biotechnology |
3.69%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.